Biocon is appointing Shreehas Tambe as Chief Executive Officer (CEO) and Managing Director effective April 1, 2026. Tambe is the first CEO of Biocon Limited, following the full integration of Biocon Biologics as its wholly owned subsidiary.

In its revamped structure, Biocon’s portfolio includes biosimilars, insulins, complex generics, and peptides, spanning diabetes, obesity, oncology, and immunology.

An Experienced CEO and Managing Director

Despite the new appointment, Tambe is not new to the company nor his roles. Prior to this announcement, he had held the same titles with Biocon Biologics, with notable success. Biocon says its $5.5 billion revenue valuation as of 2025 makes it one of the world’s top five biosimilar companies.

Tambe oversaw the acquisition of Biocon’s biosimilars business, supervising its consolidation and creating a fully integrated lab-to-patient experience. Now, he will lead Biocon’s combined platform of biosimilars and generics, strengthening abilities to operate at scale and compete globally.

“It is an honor and privilege to lead Biocon at such a pivotal moment,” Tambe said. “Biocon is among the few organizations that have transformed access to life-saving treatments by effectively leveraging science and technology … My focus will be on strengthening our foundation, consolidating our business, and accelerating sustainable growth.”

“Shreehas brings deep scientific expertise, strategic rigor, and a steadfast commitment to advancing affordable healthcare,” said Executive Chairperson Kiran Mazumdar-Shaw. “I am confident he will drive disciplined execution and translate our scale into sustained global leadership.”

Other Biocon Moves

In a related move, Siddharth Mittal will transition to a new leadership role in the Biocon Group, as yet undisclosed. Mittal joined Biocon in 2013 and served as Chief Financial Officer, then CEO and Managing Director.

Also, Kedar Upadhye is Biocon Limited’s new Chief Financial Officer.

Headquartered in India, Biocon operates in more than 120 countries and has a workforce of more than 9500.